Cel Sci CVM
NYSE CVM
$1.32 -0.09 (-6.45%)
As of: Nov 11, 2026 · 3:59 PM EST

Cel Sci (CVM) Short-term Investments (2021)

Updated

Cel Sci's Short-term Investments came in at $6.15 million for fiscal Q4 2021 (quarter ended Sep 30, 2021), down 44.8% from the prior quarter.

Analysis

Cel Sci (CVM) Short-term Investments (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Cel Sci 58.11 Mn 32.46 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 957.00
Jun 30, 2021 11.15 Mn
Mar 31, 2021 11.15 Mn
API Access

Cel Sci Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=CVM&period=max&api_key=YOUR_API_KEY